Profil
Karl Alexius Tiger Karlsson is the founder of Bluefish Pharmaceuticals AB, founded in 2005, where he held the titles of President, Chief Executive Officer & Director until 2020, and Newbury Pharmaceuticals AB, founded in 2020, where he previously held the title of Executive Chairman.
He is currently a Director at Alsakali Equity AB. Karlsson's former job experience includes being the Chief Executive Officer at Rda Interactive LLC from 2002 to 2002, where he worked from 1997 to 2002.
Karlsson received an MBA from Harvard University.
Postes actifs de Karl Karlsson
| Sociétés | Poste | Début |
|---|---|---|
| NEWBURY PHARMACEUTICALS AB | Directeur Général | 11/11/2025 |
Alsakali Equity AB | Directeur/Membre du Conseil | - |
Anciens postes connus de Karl Karlsson
| Sociétés | Poste | Fin |
|---|---|---|
Bluefish Pharmaceuticals AB
Bluefish Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops and sells generic pharmaceuticals | Fondateur | 01/03/2020 |
Rda Interactive LLC | President | 01/01/2002 |
Formation de Karl Karlsson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Bluefish Pharmaceuticals AB
Bluefish Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops and sells generic pharmaceuticals | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rda Interactive LLC | |
Newbury Pharmaceuticals AB
Newbury Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Operates as a hybrid pharmaceutical company | Health Technology |
Alsakali Equity AB |
















